SSY GROUP(02005),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02005 SSY GROUP

Trading 05-20 15:14:54

2.290

-0.020

-0.87%

High2.340	Low2.280	Vol4.05M
Open2.320	D1 Closing2.310	Amplitude2.60%
Mkt Cap6.63B	Tradable Cap6.63B	Total Shares2.90B
T/O9.32M	T/O Rate0.14%	Tradable Shares2.90B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02005","market":"HK","secType":"STK","nameCN":"SSY GROUP","latestPrice":2.29,"timestamp":1779261007391,"preClose":2.31,"halted":0,"volume":4052000,"delay":0,"changeRate":-0.008658008658008665,"floatShares":2895000000,"shares":2895000000,"eps":0.1605,"marketStatus":"Trading","change":-0.02,"latestTime":"05-20 15:14:54","open":2.32,"high":2.34,"low":2.28,"amount":9324720,"amplitude":0.025974,"askPrice":2.3,"askSize":142000,"bidPrice":2.29,"bidSize":256000,"shortable":3,"etf":0,"ttmEps":0.1605,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1779264600000},"marketStatusCode":2,"adr":0,"listingDate":1135008000000,"exchange":"SEHK","adjPreClose":2.31,"dividendRate":0.034934,"openAndCloseTimeList":[[1779240600000,1779249600000],[1779253200000,1779264000000]],"volumeRatio":0.852912,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02005","defaultTab":"news","newsList":[{"id":"1114566658","title":"SSY Group Executes HK$4.71 Million Share Buyback, Outstanding Shares Dip 0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114566658","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114566658?lang=en_us&edition=fundamental","pubTime":"2026-05-19 16:44","pubTimestamp":1779180280,"startTime":"0","endTime":"0","summary":"SSY Group Limited disclosed a share repurchase of 2.00 million ordinary shares on 19 May 2026 via on-market transactions on the Hong Kong Stock Exchange, paying between HK$2.33 and HK$2.38 per share,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185075713","title":"SSY GROUP Executes HK$4.71 Million Share Buyback on May 19","url":"https://stock-news.laohu8.com/highlight/detail?id=1185075713","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185075713?lang=en_us&edition=fundamental","pubTime":"2026-05-19 16:40","pubTimestamp":1779180033,"startTime":"0","endTime":"0","summary":"SSY GROUP (02005) announced that on May 19, 2026, the company repurchased 2 million shares at a total cost of HK$4.71 million. The repurchase price per share ranged between HK$2.33 and HK$2.38.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2460026573.USD","02005","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123977189","title":"SSY Group Repurchases 2.50 Million Shares, Treasury Stock Rises to 54.37 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1123977189","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123977189?lang=en_us&edition=fundamental","pubTime":"2026-05-18 16:22","pubTimestamp":1779092563,"startTime":"0","endTime":"0","summary":"SSY Group Limited disclosed on 18 May 2026 that it bought back 2.50 million ordinary shares on the Hong Kong Stock Exchange at prices between HK$2.30 and HK$2.37 per share, with a volume-weighted...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148828044","title":"SSY GROUP Executes Share Buyback, Spending HK$5.82 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1148828044","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148828044?lang=en_us&edition=fundamental","pubTime":"2026-05-18 16:20","pubTimestamp":1779092422,"startTime":"0","endTime":"0","summary":"SSY GROUP (02005) announced that on May 18, 2026, the company repurchased 2.5 million shares at a total cost of HK$5.82 million.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005","LU2460026573.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635704602","title":"SSY Group held annual shareholder meeting, resolutions passed by vote","url":"https://stock-news.laohu8.com/highlight/detail?id=2635704602","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635704602?lang=en_us&edition=fundamental","pubTime":"2026-05-15 16:31","pubTimestamp":1778833909,"startTime":"0","endTime":"0","summary":"SSY Group held its annual general meeting on May 15, 2026, passing all resolutions put to shareholders.Shareholders adopted audited consolidated financial statements for year ended Dec. 31, 2025, including directors’ report and independent auditor’s report.Appointment of KPMG as auditor was renewed, with board authorized to set auditor remuneration.Final dividend was declared for payment, while document did not confirm payment had been made.General mandates were granted for issuance of new shares, share repurchases, and extension of issuance mandate by adding shares repurchased, with no confirmation that any issuance or buyback has occurred.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SSY Group Ltd. published the original content us","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL7DQbNR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2460026573.USD","02005","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634247865","title":"BRIEF-SSY Group Obtains NMPA Approval For Oseltamivir Phosphate Capsules (30Mg, 45Mg And 75Mg), Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2634247865","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634247865?lang=en_us&edition=fundamental","pubTime":"2026-05-11 09:40","pubTimestamp":1778463648,"startTime":"0","endTime":"0","summary":"BRIEF-SSY Group Obtains NMPA Approval For Oseltamivir Phosphate Capsules , OthersMay 11  - SSY Group Ltd 2005.HK:OBTAINS NMPA APPROVAL FOR OSELTAMIVIR PHOSPHATE CAPSULES OBTAINS NMPA APPROVAL FOR DROTAVERINE HYDROCHLORIDE TABLETS OBTAINS NMPA APPROVAL FOR METOCLOPRAMIDE TABLETSFurther company coverage: 2005.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nFWN41L1XA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2460026573.USD","02005","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119117814","title":"SSY GROUP Secures Production Approvals for Three Pharmaceutical Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1119117814","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119117814?lang=en_us&edition=fundamental","pubTime":"2026-05-11 08:25","pubTimestamp":1778459135,"startTime":"0","endTime":"0","summary":"SSY GROUP (02005) has announced that the group has obtained drug production registration approvals from China's National Medical Products Administration for Oseltamivir Phosphate Capsules (30mg,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2460026573.USD","BK1191","02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634222014","title":"SSY Group - Obtains Nmpa Approval for Drotaverine Hydrochloride Tablets (40Mg)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634222014","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634222014?lang=en_us&edition=fundamental","pubTime":"2026-05-11 08:07","pubTimestamp":1778458075,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nFWN41L1XA:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2460026573.USD","BK1191","02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634422200","title":"SSY Group wins China NMPA approval for oseltamivir phosphate capsules","url":"https://stock-news.laohu8.com/highlight/detail?id=2634422200","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634422200?lang=en_us&edition=fundamental","pubTime":"2026-05-11 08:07","pubTimestamp":1778458071,"startTime":"0","endTime":"0","summary":"SSY Group secured China NMPA manufacturing registration approvals for oseltamivir phosphate capsules, drotaverine hydrochloride tablets, metoclopramide tablets.Approvals cover 30 mg, 45 mg, 75 mg oseltamivir for influenza treatment, prevention; 40 mg drotaverine for smooth-muscle spasm indications; 10 mg metoclopramide for nausea, vomiting, reflux.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SSY Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL4SMwcx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU2460026573.USD","02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633487457","title":"Asian Penny Stocks Under US$3B Market Cap: 3 Hidden Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2633487457","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633487457?lang=en_us&edition=fundamental","pubTime":"2026-05-08 12:04","pubTimestamp":1778213094,"startTime":"0","endTime":"0","summary":"As global markets navigate through geopolitical uncertainties and central banks hold interest rates steady, investors are increasingly looking towards Asia for unique opportunities. Penny stocks, a term that may seem outdated but remains relevant, represent smaller or newer companies that can offer surprising value. With solid financial foundations and potential for growth, these stocks might present compelling opportunities in today’s market landscape.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3231000-choice2-main-header/1585186839892","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3231000-choice2-main-header/1585186839892"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/cn/transportation/shse-600179/antong-holdings-shares/news/asian-penny-stocks-under-us3b-market-cap-3-hidden-opportunit","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/cn/transportation/shse-600179/antong-holdings-shares/news/asian-penny-stocks-under-us3b-market-cap-3-hidden-opportunit","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999014492.USD","SG9999000343.SGD","LU0164939612.USD","SG9999002679.SGD","BK6504","LU0979878070.USD","SG9999013460.SGD","600179","LU0620787316.HKD","LU0516422366.SGD","SG9999000475.SGD","SGXZ24219693.SGD","BK1144","LU0516423174.USD","SG9999014484.SGD","BK6057","LU1242518931.SGD","LU0516423091.SGD","SG9999013486.USD","02005","BK6081","SG9999004360.SGD","SG9999013478.USD","01057","LU0082770016.SGD","BK6065","SGXZ27511609.SGD","SGXZ58947870.SGD","LU0516422952.EUR","LU0516422440.USD","002703","SG9999016042.SGD","SGXZ43160589.SGD","SG9999003826.SGD","BK8040","LU1242518857.USD","LU0082770016.USD","BK6515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144838627","title":"SSY Group Gains NMPA Clearance for 1 ml:1 mg Cyanocobalamin Injection and Secures Second Consistency-Evaluation Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1144838627","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144838627?lang=en_us&edition=fundamental","pubTime":"2026-05-07 16:44","pubTimestamp":1778143482,"startTime":"0","endTime":"0","summary":"SSY Group Limited announced that China’s National Medical Products Administration (NMPA) has approved two key milestones for the company’s Cyanocobalamin (Vitamin B12) Injection: • Addition of a 1...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196613819","title":"SSY GROUP's Vitamin B12 Injection Gains Approval for New 1ml:1mg Specification","url":"https://stock-news.laohu8.com/highlight/detail?id=1196613819","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196613819?lang=en_us&edition=fundamental","pubTime":"2026-05-07 16:38","pubTimestamp":1778143109,"startTime":"0","endTime":"0","summary":"SSY GROUP (02005) has announced that its Vitamin B12 injection has received approval from China's National Medical Products Administration to add a 1ml:1mg specification. The product also passed the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005","LU2460026573.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633311688","title":"SSY Group wins China NMPA approval for new Vitamin B12 injection specification","url":"https://stock-news.laohu8.com/highlight/detail?id=2633311688","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633311688?lang=en_us&edition=fundamental","pubTime":"2026-05-07 16:32","pubTimestamp":1778142723,"startTime":"0","endTime":"0","summary":"SSY Group secured China NMPA clearance for added 1 ml:1 mg specification for its Cyanocobalamin  Injection.Regulator also granted consistency evaluation approval for the product, marking SSY’s second such approval for its PRC entities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SSY Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL8p7Wvw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU2460026573.USD","02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633168301","title":"SSY Group - China Approves 1Ml:1Mg Specification and Consistency Evaluation for SSY Group's Cyanocobalamin Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2633168301","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633168301?lang=en_us&edition=fundamental","pubTime":"2026-05-07 16:31","pubTimestamp":1778142660,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K04Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2460026573.USD","02005","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118279755","title":"Orient Securities Plans to Acquire Full Stake in Shanghai Securities via A-Share Issuance and Cash Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=1118279755","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118279755?lang=en_us&edition=fundamental","pubTime":"2026-05-07 09:06","pubTimestamp":1778115988,"startTime":"0","endTime":"0","summary":"Major Developments: SSY GROUP (02005) has obtained production registration approval for Doxazosin Mesylate Sustained-Release Tablets (4mg) and other pharmaceutical products. SBP GROUP (01177)...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK0028","BK1521","IE00BZ08YT58.USD","LU2460026573.USD","BK1147","BK1515","BK1564","IE00BZ08YS42.EUR","BK1191","BK1589","BK0012","02005","BK1227","BK4585","161027","01177","03958","HK0000165453.HKD","600958","BK0183","399300","BK0276","BK0188","VXUS","159982","IE00BZ08YR35.GBP","01466"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633340189","title":"BRIEF-SSY Group Test Kits Obtain Medical Device Registration In Hebei, China","url":"https://stock-news.laohu8.com/highlight/detail?id=2633340189","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633340189?lang=en_us&edition=fundamental","pubTime":"2026-05-06 18:22","pubTimestamp":1778062951,"startTime":"0","endTime":"0","summary":"BRIEF-SSY Group Test Kits Obtain Medical Device Registration In Hebei, ChinaMay 6 (Reuters) - SSY Group Ltd 2005.HK:TEST KITS OBTAIN MEDICAL DEVICE REGISTRATION IN HEBEI, CHINAFULL-RANGE C-REACTIVE PR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nFWN41J0H2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005","BK1191","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174382331","title":"SSY Group Secures Hebei Regulatory Approval for Full-Range CRP and SAA/CRP Diagnostic Test Kits","url":"https://stock-news.laohu8.com/highlight/detail?id=1174382331","media":"Bulletin Express","labels":["policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174382331?lang=en_us&edition=fundamental","pubTime":"2026-05-06 17:03","pubTimestamp":1778058196,"startTime":"0","endTime":"0","summary":"SSY Group Limited announced on 6 May 2026 that its Full-range C-reactive protein (hsCRP + conventional CRP) Test Kit and Serum Amyloid A / C-reactive protein (SAA/CRP) Test Kit have received medical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115036802","title":"SSY GROUP Receives Medical Device Registration Certificates for Two Diagnostic Kits in Hebei","url":"https://stock-news.laohu8.com/highlight/detail?id=1115036802","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115036802?lang=en_us&edition=fundamental","pubTime":"2026-05-06 16:50","pubTimestamp":1778057426,"startTime":"0","endTime":"0","summary":"SSY GROUP (02005) announced that its two medical device products—the Full-range C-reactive Protein (hsCRP + conventional CRP) Detection Kit (Fluorescence Immunochromatography) and the Serum Amyloid...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","09997","BK1191","BK1100","BK1583","09996","LU2460026573.USD","BK1222","SAA","159883","02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633590061","title":"SSY Group wins China Hebei approval for full-range CRP test kit","url":"https://stock-news.laohu8.com/highlight/detail?id=2633590061","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633590061?lang=en_us&edition=fundamental","pubTime":"2026-05-06 16:45","pubTimestamp":1778057129,"startTime":"0","endTime":"0","summary":"Certificate also covered a combined Serum Amyloid A/C-reactive protein test kit, expanding its diagnostic portfolio for inflammation-related testing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SSY Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL2hCCkF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005","LU2460026573.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633009869","title":"SSY Group - Full-Range C-Reactive Protein Test Kit, Other Kit Got Medical Device Registration Certificates From Hebei Provincial Drug Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2633009869","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633009869?lang=en_us&edition=fundamental","pubTime":"2026-05-06 16:45","pubTimestamp":1778057112,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nFWN41J0H2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02005","BK1191","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ssygroup.com.hk","stockEarnings":[{"period":"1week","weight":-0.0168},{"period":"1month","weight":-0.0565},{"period":"3month","weight":-0.2252},{"period":"6month","weight":-0.2174},{"period":"1year","weight":-0.167},{"period":"ytd","weight":-0.1731}],"compareEarnings":[{"period":"1week","weight":-0.0209},{"period":"1month","weight":-0.0139},{"period":"3month","weight":-0.034},{"period":"6month","weight":-0.0015},{"period":"1year","weight":0.1057},{"period":"ytd","weight":0.0065}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.","yearOnYearQuotes":[{"month":1,"riseRate":0.52381,"avgChangeRate":0.008314},{"month":2,"riseRate":0.52381,"avgChangeRate":0.02049},{"month":3,"riseRate":0.666667,"avgChangeRate":0.079064},{"month":4,"riseRate":0.47619,"avgChangeRate":0.031009},{"month":5,"riseRate":0.47619,"avgChangeRate":0.010209},{"month":6,"riseRate":0.5,"avgChangeRate":0.067908},{"month":7,"riseRate":0.35,"avgChangeRate":-0.027819},{"month":8,"riseRate":0.35,"avgChangeRate":-0.017769},{"month":9,"riseRate":0.3,"avgChangeRate":-0.04678},{"month":10,"riseRate":0.45,"avgChangeRate":-0.001982},{"month":11,"riseRate":0.65,"avgChangeRate":0.086372},{"month":12,"riseRate":0.5,"avgChangeRate":-0.009169}],"exchange":"SEHK","name":"SSY GROUP","nameEN":"SSY GROUP"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SSY GROUP(02005),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SSY GROUP(02005) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SSY GROUP,02005,SSY GROUP股票,SSY GROUP股票老虎,SSY GROUP股票老虎国际,SSY GROUP行情,SSY GROUP股票行情,SSY GROUP股价,SSY GROUP股市,SSY GROUP股票价格,SSY GROUP股票交易,SSY GROUP股票购买,SSY GROUP股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SSY GROUP(02005),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SSY GROUP(02005) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}